标普全球核心电池金属ETF-Proshares ION 深 沪
等待开盘 08-13 09:30:00 美东时间
34.8467
+0.036
+0.10%
华盛通- 最 高34.8684
- 今 开34.67
- 成交量 3348股
- 最 低 34.44
- 昨 收 34.811
- 总市值 348.47万
- 52周最高 34.97
- 市盈率 静 --
- 换手率 3.35%
- 52周最低 20.4544
- 委 比 0.00%
- 总股本 10.00万
- 历史最高 44.7747
- 量 比 1.21
- 振 幅 1.23%
- 历史最低 20.4544
- 每 手 1
- 风险率 2.38%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多CORRECTION: Xenon Pharmaceuticals Q2 EPS $(1.07) Misses $(0.99) Estimate
Xenon Pharmaceuticals (NASDAQ:XENE) reported quarterly losses of $(1.07) per share which missed the analyst consensus estimate of $(0.99) by 7.65 percent. This is a 42.67 percent decrease over losses of $(0.75) per share
08-12 21:51
G. WILLI-FOOD INTERNATIONAL ANNOUNCES DIVIDEND DISTRIBUTION OF NIS 20 MILLION (US$5.8 MILLION)
YAVNE, Israel, Aug. 12, 2025 /PRNewswire/ -- G. Willi-Food International Ltd. (NASDAQ: WILC) (TASE: WILF) (the "Company" or "Willi-Food"), a global company that specializes in the developmen...
08-12 20:20
NEXION Group Ltd Raises $80,000 Through Convertible Notes Issuance
Nexion Group Ltd. ( ($AU:NNG) ) just unveiled an announcement. NEXION Group Ltd...
08-12 10:57
Compass Therapeutics rises after pipeline updates
Shares of Compass Therapeutics (NASDAQ:CMPX) added ~21% on Monday after the cancer drug developer, with its Q2 2025 results, announced a lower-than-expected number of mortalities in a Phase 2/3 trial ...
08-12 01:55
CORRECTION: McCoy Global Q2 EPS $0.05 Down From $0.11 YoY, Sales $24.051M Up From $19.910M YoY
McCoy Global (TSX:MCB) reported quarterly earnings of $0.05 per share. This is a 54.55 percent decrease over earnings of $0.11 per share from the same period last year. The company reported $24.051 million in sales this
08-11 22:21
Get Private Equity-Style Huge Returns Without The Massive Fees
The movement to open U.S. retirement plans to private equity and venture capita...
08-09 02:21
Fuso Pharmaceutical Unveils FUSO VISION 2030 Next Stage Plan
Fuso Pharmaceutical Industries,Ltd. ( ($JP:4538) ) has issued an update. Fuso P...
08-08 15:28
LIONSGATE REPORTS RESULTS FOR FIRST QUARTER FISCAL 2026
Studio Revenue was $556 Million; Net Loss From Continuing Operations Attributable to Shareholders was $94.0 Million or $0.35 Diluted Net Loss Per Share Adjusted Net Loss from Continuing Oper...
08-08 04:05
CORRECTION: AppLovin Sees Q3 Sales $1.320B-$1.340B vs $1.314B Est
Third Quarter 2025 Financial Guidance Summary:(In millions, except percentages)3Q25 Low HighRevenue$1,320 $1,340 Adjusted EBITDA$1,070 $1,090 Adjusted EBITDA
08-07 05:44
Watts Water Technologies Raises FY2025 Sales Guidance from $2.207B-$2.320B to $2.297B-$2.365B vs $2.283B Est
2025 FULL YEAR OUTLOOK – RECONCILIATION OF NET SALES GROWTH TO ORGANIC SALES GROWTH AND OPERATING MARGIN TO ADJUSTED OPERATING MARGIN(Unaudited) Total Watts Full
08-07 05:09
